CD274 and non-small cell lung carcinoma: Similarly promising results have been achieved in a cohort of 399 NSCLC patients with an ML methodology using CT- and PET/CT radiomics; CT radiomics outperformed selected features from other imaging modalities in both PD-L1 TPS > 1% (AUC: 0.97) and TPS > 50% (AUC: 0.80) [56].